Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01685606 · ClinicalTrials.gov registry record · Phase 2
Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma
A Phase 2 study, sponsored by Brown University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT01685606: Clinical Trial Phase 2 study, sponsored by Brown University.
NCT01685606 is a Phase 2 study that was terminated before completion, run by Brown University. The registered enrollment target is 6 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01685606, a Phase 2 study, was terminated before completion, sponsored by Brown University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The study of whether an infusion of blood cells called lymphocytes from a donor can stimulate the immune system to fight your leukemia/lymphoma.
Primary Outcome
Criteria for AML and ALL (adapted from Cheson et al.20) Complete remission (CR) is defined as the presence of all of the following * Peripheral blood o No leukemic blasts present. * No extramedullary findings of leukemia or disappearance of such (i.e. CNS or soft tissue involvement) * Bone marrow * Cellularity \>20% with baseline maturation. * No Auer rods * Less than 5% blast cells. * Complete blood counts and bone marrow normalization criteria must be met within one week of each ot
Interventions
- BIOLOGICAL cellular immunotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-06 |
| Phase | Phase 2 |
Why NCT01685606 stopped before completion
NCT01685606 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which cellular immunotherapy is the first listed.
NCT01685606 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01685606 about?
NCT01685606 is a clinical study titled "Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma". The study of whether an infusion of blood cells called lymphocytes from a donor can stimulate the immune system to fight your leukemia/lymphoma.
What is the current status of trial NCT01685606?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2013-03. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01685606?
The interventions under investigation include: cellular immunotherapy (BIOLOGICAL).
Who is sponsoring clinical trial NCT01685606?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01685606's enrollment target sits among peer trials
6 1996th of 2000 higher than 1 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia